Their study has discovered that subtle changes in lung scarring over just one year, as measured by quantitative computed tomography imaging, are strongly linked to future lung-function decline and ...

Caleigh has struggled most of her life with a difficult lung disease, but she never lets it get the best of her.

Pulmonary fibrosis—also known in technical terms as idiopathic pulmonary fibrosis (IPF)—is a rare but life-threatening ...

Insilico Medicine to showcase generative AI platform and introduce their latest AI-driven Pulmonary Fibrosis clinical research at PFF Summit 2025 in Chicago, IL ...

Brensocatib, a DPP1 inhibitor, is the first FDA-approved therapy for non-cystic fibrosis bronchiectasis, showing significant clinical and structural benefits. The ASPEN trial demonstrated that ...

Introduction: On CT, small size pulmonary artery (PA) thrombus is sometimes difficult to detect and diagnostic accuracy depends on the physician’s skill. Hypothesis: Using novel spectral CT, an ...

Abstract: Monitoring lung cancer patients' pulmonary function properly, particularly previous to surgery, is crucial from a clinical standpoint. This information can aid doctors in keeping tabs on ...

Abstract: Automatic construction of pulmonary vascular trees (PVTs) from computer tomography (CT) images is a critical step for computer-assisted diagnosis and treatment planning of pulmonary diseases ...

Blocking caspase-9 — an enzyme involved in programmed cell death, or apoptosis — may halt or reverse tissue scarring in pulmonary fibrosis (PF), according to a new preclinical study. Researchers found ...

Data presented at the CHEST 2025 Annual Meeting highlight deupirfenidone’s differentiated profile and potential to address unmet needs across age groups BOSTON--(BUSINESS WIRE)--PureTech Health plc ...